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Summary
 Aim This investigation presents the estimation of cytogenetic injury in human peripheral blood lym-
phocytes and its dependence on the dose and quality of ionizing radiation applied in radiothera-
py of cancer patients with the purpose of calculating RBE values for different radiation sources in 
the dose range under study.
 Materials/Methods Cytogenetic dosimetry was carried out at an exposure of human lymphocyte cultures to 137Cs and 
60Co therapeutic sources and neutrons with average energies of 6 and 22 MeV.
 Results Increase in dose reduces RBE values of 137Cs g-irradiation, which in the range of doses investigat-
ed (0.3–5.0 Gy) vary between 3.5–1.3, respectively. Thus the difference in RBE values can be most 
accurately determined in the 0.5–2.0 Gy dose interval usually used in radiotherapy. Comparative 
estimation of fast neutron RBE values showed that 6 MeV neutrons give signiﬁ cantly higher yields 
of chromosome aberrations as compared with 22 Mev neutrons. It was shown that cytogenetic ef-
fectiveness has a tendency to decrease with the increase in the depth of the water phantom. The 
largest effect was observed at the depth of up to 6 cm.
 Conclusions The results of our pre-clinical studies indicate that radiation-induced effects simultaneously de-
pend on different irradiation parameters such as dose, energy and the depth of the irradiated bi-
ological object, which should be taken into account in radiotherapy of cancer patients.
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BACKGROUND
The examination of radiobiological parameters of ionizing 
radiation from radiotherapeutic sources afford opportunity 
to choose the necessary exposure requirements for patients. 
A therapeutic ionising radiation source should be examined 
radiobiologically including the evaluation of its relative bio-
logical effectiveness (RBE) dependent on radiation quality, 
dose, cell radiosensitivity etc. [1]. The investigation of radia-
tion-induced cytogenetic injury levels in human cells seems to 
be a good method of investigation due to the leading role of 
structural chromosome rearrangements in the development 
of radiation damage and post-radiation cell death [2].
It is known that RBE estimation of a new ionising radiation 
is the most important piece of information in clinical radio-
biology and radiotherapy. The exact knowledge of RBE val-
ues is necessary for correct planning of radiation burden on 
normal and tumour tissues. The absence of convincing lit-
erature data on the biological effectiveness of 137Cs g-radia-
tion required that its RBE be estimated for intracavitary ra-
diotherapy of cancer patients at the Institute of Oncology 
of AMS of Ukraine, based on the estimation of chromosome 
changes in human peripheral blood lymphocytes and on its 
comparison with the effects of a traditional 60Co g-source. 
Application of 6 MeV neutrons in radiotherapy of human 
tumours in Ukraine, based on the Bio-medical Complex 
of U-120 Cyclotron at the Institute of Nuclear Research of 
NAS of Ukraine, gave us the opportunity to carry out ad-
ditional radiobiological research of neutron RBE depend-
ence on various parameters of irradiation.
AIM
This investigation presents data on the estimation of cytoge-
netic damage of human peripheral blood lymphocytes and 
its dependence on the dose and quality of ionising radia-
tion applied in radiotherapy of cancer patients with the pur-
pose of calculating RBE values for various radiation sourc-
es in the dose range investigated.
MATERIALS AND METHODS
Biological dosimetry was carried out at an exposure of hu-
man lymphocyte cultures to therapeutic sources of 137Cs 
(“Selectron”), 60Co (“Rocus”), neutrons with average ener-
gy of 6 and 22 MeV (U-120 and U-240 Cyclotron). The test 
system of human peripheral blood lymphocyte culture with 
metaphase analysis of chromosomal aberrations was used as 
a method of biological dosimetry [2]. Lymphocyte cultures 
were established from blood samples of 20 patients according 
to the modiﬁ ed method of Moorhead [3]. After exposure, 
lymphocytes were incubated in a RPMI-1640 medium contain-
ing 0.2 µg/ml PHA (Difco, USA) and 15% foetal calf serum 
for 52 hours (2 last hours with colchicine). This procedure 
made it possible to analyse cells in the ﬁ rst post-radiation mi-
tosis. After hypotonic treatment with 75 mM KCl, lymphocytes 
were treated with freshly prepared 3:1 methanol/acetic acid 
ﬁ xative. Then the cell suspension was applied to frost wet 
slides and dried. Preparations were hydrolysed in 5N HCl, 
washed and stained with 2% Giemsa solution.
The analysis of stained chromosome preparations was accom-
panied by visual karyotyping. Chromatid-type (interchang-
ings, deletions, isodeletions) and chromosome-type (paired 
fragments, minute chromosomes, rings, dicentrics and anom-
alous monocentrics) aberrations were scored. 300–400 met-
aphases were analysed for each point examined.
Lymphocyte cultures were exposed to fast neutrons with an 
average energy of 6 MeV in the 0.05–2.00 Gy dose range and 
at the 0.16 Gy/min dose rate (g-rays contamination did not 
exceed 8–10%). Experiments in fast neutron RBE determi-
nations were carried out at an exposure of lymphocyte cul-
tures in an air and tissue equivalent phantom.
Lymphocyte cultures were exposed to fast neutrons with 22 
MeV average energy in the 0.01–4.00 Gy dose range and at 1.00 
Gy/min dose rate (g-rays contribution did not exceed 5%). 
Dosimetry of the absorbed dose of fast neutrons was carried 
out with a Va-R-253 ionisation chamber and a Va-J-18 dosim-
eter by direct measurements of the charge on the target.
Similar experiments were carried out for 60Co g-rays for the 
comparison and as a reference dose to obtain RBE values. 
An ionisation chamber and a ferrosulfate dosimeter were 
used for the dosimetry of the absorbed doses. Lymphocyte 
cultures were exposed to 0.15–0.30 Gy the dose range of 
137Cs g-rays at the 2.00 Gy/min dose rate and in the 0.3–5.0 
Gy dose range of 60Co at the 2.2 Gy/min dose rate.
Lymphocyte cultures were irradiated in G0 phase of cell 
cycle [4].
RESULTS
The comparative analysis of chromosome radiosensitivity to 
60Co and 137Cs g-photons demonstrated higher cytogenet-
ic effectiveness of 137Cs and made it possible to determine 
RBE dose dependence (Figure 1).
The increase in the dose led to the lower RBE values of 137Cs 
g-rays which in the range of doses investigated (0.3–5.0 Gy) 
varied between 3.5 and 1.3, respectively. Thus a difference 
in RBE values was most accurately determined in the 0.5–
2.0 Gy dose range usually used in radiotherapy.
The RBE dose dependence of neutrons (22 MeV) calculat-
ed according to the criterion of total chromosome aberra-
tions in lymphocytes is shown in Table 1. In the 0.2–4.0 Gy 
dose range, RBE decreases from 2.8 to 1.0. The difference 
in RBE values is most precisely determined in the 0.2–2.0 
Gy dose range usually used in radiation therapy.
Figure 2 shows fast neutrons RBE dose dependence. RBE 
values estimated according to the yields of chromosome ab-
errations and percent of the cells containing aberrations 
do not differ but they change for neutrons from 5.2 to 2.6 
and 5.7 to 2.1 within the 0.4–2.2 Gy dose range, respec-
tively. Comparative estimation of fast neutron RBE values 
(Table 1, Figure 2) shows that 6 MeV neutrons give a more 
effective chromosome aberration yield as compared with 22 
MeV neutrons. For example, at 0.5 Gy the RBE value for 22 
MeV neutrons is 2.4 and that for 6 MeV neutrons is twice 
as high. However, at 2.0 Gy the RBE value for 22 MeV en-
ergy neutrons is 1.37 and for 6 MeV it is 2.6. This fact con-
ﬁ rms the general tendency: the increase in dose and ener-
gy leads to a decrease in neutron RBE values. The RBE for 
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neutrons with different energies takes only an approximate 
value due to the induction of the “excess” damage when the 
irradiation dose increases [5].
The application of neutron radiation in radiobiological 
experiments requires good dosimetry and investigation 
of neutron beam parameters. Comparative examination 
of the absorbed dose decrease in air and in a tissue-equiv-
alent material was one of the important tasks of this study. 
Additionally, during the exposure of large biological ob-
jects it is necessary to take into account irregularity of ir-
radiation caused by the attenuation of the primary beam. 
Given all these facts we studied the dependence of cytoge-
netic changes caused by 6 MeV energy neutrons in the 
0.25–2.20 Gy dose range on the tissue-equivalent phan-
tom depth.
Experimental cytogenetic data indicate the absence of re-
liable differences in the cytogenetic injury of lymphocytes 
after neutron irradiation of human lymphocyte culture 
in phantom (depth of 2.6 and 10.0 cm along the axis of 
the beam) in comparison with that irradiated in air. It was 
shown that cytogenetic effectiveness has a tendency to de-
crease with the increase in the depth of the water phan-
tom. The largest decrease was observed at the depth of up 
to 6 cm (Figure 3).
DISCUSSION
The following factors speciﬁ ed in the present study indicat-
ed higher effectiveness of 137Cs in comparison with 60Co irra-
diation. First, our radiobiological study was conducted un-
der conditions approximating to the maximum the in vivo 
(clinical) circumstances, i.e. including a steep dose gradi-
ent in the irradiated volume. Second, the energy of 137Cs 
g-rays is half as low as the energy of 60Co g-rays. Cytogenetic 
data on 137Cs RBE values which exceed the value of one in 
agreement with the investigations made on the basis of hu-
man chromosome damage estimations and of the degree 
of radiation pathomorphosis of the endometrium malig-
nant neoformation [6,7]. Thus made it possible to deter-
mine the tendency to lower 137Cs g-ray effectiveness in com-
parison with 60Co irradiation.
The interest in the studies of neutron RBE is caused by the 
need to establish radiation safety norms, to make risk as-
sessment for exposed personnel and to formulate and im-
prove an appropriate protocol for neutron therapy [8]. We 
have shown that the cytogenetic effectiveness of neutrons 
has a tendency to decrease with the increase in the phan-
tom depth. This can be due to the ﬁ ltration of low-ener-
gy neutrons at the depth of the irradiated object, which is 
very important for radiotherapy planning in cases of deep-
ly located tumours. Thus the estimation of neutron effec-
tiveness requires detailed physical and biological dosime-
try measurements.
Figure 1. RBE dose dependence of 137 Cs g-rays: 1- RBE average value; 
2 and 3 – 95% conﬁ dence limits.
Dose, Gy RBE value
 0.2  2.80
 0.5  2.44
 1.0  1.86
 2.0  1.37
 3.0  1.13
 4.0  1.0
Table 1. 22 MeV neutron RBE dose dependence.
Figure 2. Fast neutron (6 MeV) RBE dependence on dose according to the 
frequency of chromosome aberrations (1) and damaged cells (2).
Figure 3. Dependence of neutron eﬀ ectiveness on the depth of a water 
phantom according to the total chromosome aberration frequency. 
Solid line represents neutrons and accompanying g-rays; dashed line 
– neutrons only.
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Variegated dependence of chromosome aberration frequen-
cies on the radiation dose and neutron energy that leads to 
neutron RBE value higher than 1 can be explained by the 
LET dependence on the energy of irradiation and by the 
inﬂ uence of the micro-distribution of absorbed energy in 
the volume of cell nucleus.
The cytogenetic results obtained showing that the neutron 
RBE value decreases with the increase in their energy (6, 
22 MeV) in the dose range studied are in agreement with 
the data on RBE estimation of 0.37 and 0.57 MeV neu-
trons during the exposure of human peripheral blood lym-
phocyte culture [1]. Similar RBE dependence on neutron 
energy was shown in the assessment of cell survival and on-
cogenic transformation of C3H10T1/2 cells exposed to 
0.35 MeV and 13.7 MeV neutrons [9]. The data presented 
in this study were taken into account in neutron therapy 
planning for deeply located tumours [10, 11] and in intrac-
avitar radiotherapy of patients with malignant endometri-
um neoplasms [12].
CONCLUSIONS
The results of radiobiological studies based on cytogenet-
ic effects indicate that RBE values of fast neutrons (6 and 
22 MeV) depend on their energies and on the depth of 
the irradiated biological object. The RBE of 137Cs g-rays es-
timated according to the frequency of chromosome aber-
rations in human peripheral blood lymphocytes in a dose 
range of 0.15–3.00 Gy exceeds 1 and reaches the highest 
values at lower doses.
REFERENCES:
 1. Kimio T, Natarajan G, Satoru E et al: Neutron-energy-dependent 
initial DNA damage and chromosomal exchange. J Radiat Res, 1999; 
40: 36–44
 2. IAEA: Biological dosimetry: chromosomal aberration analysis 
for dose assessment/ Technical Report # 260. Vienna: Internat. Atomic 
Energy Agency, 1986
 3. Moorhead PS, Nowell PC, Mellmann WJ et al: Chromosome 
preparations of leucocytes cultured from human peripheral blood. Exp 
Cell Res, 1960; 20: 613–16
 4. Sevankaev AV: Radiosensitivity of human lymphocyte chromo-
somes in mitotic cycle. M: Energoatomizdat, 1987: 160
 5. Dyomina EA, Chernichenko VA, Chebotarev EY, Gulko GM: 
Cytogenetic effects of 22 MeV neutrons. Cytology and Genetics, 1990; 
24: 4–43
 6. Lucas JN, Tenjin T, Straume T: Rapid human chromosome ab-
erration analysis using ﬂ uorescence in situ hybridization. Int J Radiaat 
Biol, 1989; 1(56): 35–44
 7. Titova VA, Heteev MV, Zukovskyi YA: Intracavitary radiothera-
py of endometrium cancer, computer planning and realisation of treat-
ment programs with AGAT-VU apparatus. Med Radiol, 1989; 9: 38–49
 8. Wambersie A: Neutron therapy: from radiobiological expecta-
tion to clinical reality. In: Progress in Radioncology V, Lippincott-Raven, 
New-York 1995; 685–90
 9. Miller RC, Marino SA, Martin SG et al: Neutron-energy-dependent 
cell survival and oncogenic transformation. J Radiat Res,1999; 40: 53–59
 10. Gulko GM, Dyomina EA, Chernichenko VA: Changes of cytogenetic ef-
fectiveness of the therapeutic ray of fast neutrons in water phantoms. 
Radiobiol Radiother, 1989; 30: 5
 11. Chernichenko VA, Monich AY, Dyomina EA, Svarichevskaya EV; Method 
of radiation dose estimation of tumors during neutron therapy. Ŕuthor 
Ńertiﬁ cate No 4101772; 1480180. MKI. Bullet. 1989; 18: 2
 12. Chernichenko VA, Ivankova VS, Dyomina EA, Zlochevska LL: Treatment 
of patients with endometrium malignant neoplasm using g-source of 
Cs. Vrach Delo, 1991;12: 81
Original Paper Rep Pract Oncol Radiother, 2005; 10(1): 43-46
46
